找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinical Ophthalmic Oncology; Orbital Tumors Catherine J. Hwang,Bhupendra C.K. Patel,Arun D. Si Book 2019Latest edition Springer Nature Swi

[復制鏈接]
樓主: 夸大
41#
發(fā)表于 2025-3-28 16:36:15 | 只看該作者
Orbital Tumors: Differential Diagnosis in Adults,ing studies. In general, well-circumscribed lesions are more likely to be benign such as a cavernous hemangioma, fibrous histiocytoma, lipoma, neurofibroma, schwannoma or neurilemmoma, and pleomorphic adenoma. Conversely, malignant tumors more commonly present with a diffuse infiltrative pattern.
42#
發(fā)表于 2025-3-28 19:40:17 | 只看該作者
Orbital Meningioma, structures makes surgery demanding and challenging. “There is nothing in the whole realm of surgery more gratifying than the successful removal of a meningioma with subsequent perfect functional recovery” (Harvey Cushing, 1922).
43#
發(fā)表于 2025-3-29 00:40:52 | 只看該作者
Die Prinzipien der empirischen Forschung,an adjacent structure), or metastatic (from distant structures). Orbital neoplasia can be divided into histological categories that include benign, benign but locally aggressive, and malignant. In some cases, especially lymphoproliferative lesions, a spectrum from benign to malignant exists.
44#
發(fā)表于 2025-3-29 06:24:14 | 只看該作者
45#
發(fā)表于 2025-3-29 09:00:52 | 只看該作者
Entwurf relationaler Datenbanken, and extent of disease involvement, there are multiple forms of focal and systemic therapy. The 10-year, disease-specific mortality is approximately 5–10%. Many of the advances in OAL management originated from improvements in our understanding of systemic lymphoma.
46#
發(fā)表于 2025-3-29 14:19:10 | 只看該作者
47#
發(fā)表于 2025-3-29 16:04:48 | 只看該作者
48#
發(fā)表于 2025-3-29 20:46:53 | 只看該作者
Classification of Orbital Tumors,an adjacent structure), or metastatic (from distant structures). Orbital neoplasia can be divided into histological categories that include benign, benign but locally aggressive, and malignant. In some cases, especially lymphoproliferative lesions, a spectrum from benign to malignant exists.
49#
發(fā)表于 2025-3-30 00:46:27 | 只看該作者
50#
發(fā)表于 2025-3-30 08:06:16 | 只看該作者
Orbital and Adnexal Lymphoma, and extent of disease involvement, there are multiple forms of focal and systemic therapy. The 10-year, disease-specific mortality is approximately 5–10%. Many of the advances in OAL management originated from improvements in our understanding of systemic lymphoma.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-11 09:51
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
八宿县| 新河县| 莎车县| 盐亭县| 沙河市| 湘潭县| 潼关县| 临汾市| 上蔡县| 屯昌县| 石屏县| 将乐县| 那曲县| 金阳县| 庆阳市| 巴楚县| 田东县| 蓬莱市| 南昌市| 砚山县| 开平市| 秦皇岛市| 磐安县| 郯城县| 乌拉特后旗| 吉水县| 莱西市| 水富县| 乐至县| 长乐市| 武威市| 乌拉特前旗| 安化县| 金川县| 都兰县| 宣化县| 南漳县| 禹城市| 即墨市| 敦化市| 武鸣县|